» Articles » PMID: 16102372

Historical Trends in the Production and Consumption of Illicit Drugs in Mexico: Implications for the Prevention of Blood Borne Infections

Overview
Publisher Elsevier
Specialty Psychiatry
Date 2005 Aug 17
PMID 16102372
Citations 113
Authors
Affiliations
Soon will be listed here.
Abstract

Mexico has cultivated opium poppy since before the 1900's and has been an important transit route for South American cocaine for decades. However, only recently has drug use, particularly injection drug use, been documented as an important problem. Heroin is the most common drug used by Mexican injection drug users (IDUs). Increased cultivation of opium poppy in some Mexican states, lower prices for black tar heroin and increased security at U.S.-Mexican border crossings may be contributing factors to heroin use, especially in border cities. Risky practices among IDUs, including needle sharing and shooting gallery attendance are common, whereas perceived risk for acquiring blood borne infections is low. Although reported AIDS cases attributed to IDU in Mexico have been low, data from sentinel populations, such as pregnant women in the Mexican-U.S. border city of Tijuana, suggest an increase in HIV prevalence associated with drug use. Given widespread risk behaviors and rising numbers of blood borne infections among IDUs in Mexican-U.S. border cities, there is an urgent need for increased disease surveillance and culturally appropriate interventions to prevent potential epidemics of blood borne infections. We review available literature on the history of opium production in Mexico, recent trends in drug use and its implications, and the Mexican response, with special emphasis on the border cities of Ciudad Juarez and Tijuana.

Citing Articles

Differences in characteristics and interactions with close contacts among PWID in the San Diego Border Region before and during the COVID-19 pandemic.

Marquez L, Martin N, Strathdee S, Skaathun B J Migr Health. 2024; 10:100267.

PMID: 39403696 PMC: 11471669. DOI: 10.1016/j.jmh.2024.100267.


Risk Factors Associated with Hepatitis C Subtypes and the Evolutionary History of Subtype 1a in Mexico.

Laguna-Meraz S, Jose-Abrego A, Roman S, Leal-Mercado L, Panduro A Viruses. 2024; 16(8).

PMID: 39205233 PMC: 11359553. DOI: 10.3390/v16081259.


Population-Based Correlates of Spatially Aggregated Drug-Related Arrests On and Off the U.S.-Mexico Border in California.

Caetano R, Vaeth P, Gruenewald P, Ponicki W, Kaplan Z, Annechino R J Stud Alcohol Drugs. 2022; 83(3):323-331.

PMID: 35590172 PMC: 9134994.


The introduction of fentanyl on the US-Mexico border: An ethnographic account triangulated with drug checking data from Tijuana.

Friedman J, Bourgois P, Godvin M, Chavez A, Pacheco L, Segovia L Int J Drug Policy. 2022; 104:103678.

PMID: 35421740 PMC: 9169560. DOI: 10.1016/j.drugpo.2022.103678.


He is the Same as Me Key Populations' Acceptability and Experience of a Community-Based Peer Navigator Intervention to Support Engagement in HIV Care in Tijuana, Mexico.

Rocha-Jimenez T, Pitpitan E, Cazares R, Smith L AIDS Patient Care STDS. 2021; 35(11):449-456.

PMID: 34665000 PMC: 8817705. DOI: 10.1089/apc.2021.0069.


References
1.
Strathdee S, Zafar T, Brahmbhatt H, Baksh A, ul Hassan S . Rise in needle sharing among injection drug users in Pakistan during the Afghanistan war. Drug Alcohol Depend. 2003; 71(1):17-24. DOI: 10.1016/s0376-8716(03)00072-3. View

2.
Strathdee S, Fraga W, Case P, Firestone M, Brouwer K, Perez S . "Vivo para consumirla y la consumo para vivir" ["I live to inject and inject to live"]: high-risk injection behaviors in Tijuana, Mexico. J Urban Health. 2005; 82(3 Suppl 4):iv58-73. PMC: 2196210. DOI: 10.1093/jurban/jti108. View

3.
Parfitt T . Drug addiction and HIV infection on rise in Tajikistan. Lancet. 2003; 362(9391):1206. DOI: 10.1016/S0140-6736(03)14560-6. View

4.
Khalsa J, Francis H, Mazin R . Bloodborne and sexually transmitted infections in drug abusers in the United States, Latin America, the Caribbean, and Spain. Clin Infect Dis. 2003; 37 Suppl 5:S331-7. DOI: 10.1086/377543. View

5.
Inchaurraga S . Drug use, harm reduction, and health policies in Argentina: obstacles and new perspectives. Clin Infect Dis. 2003; 37 Suppl 5:S366-71. DOI: 10.1086/377564. View